THE PEOPLE'S ANGER HAS ROOTS WHICH THE IMF FAILS TO ACKNOWLEDGE
In: World trade union movement: review of the World Federation of Trade Unions, Heft 12, S. 29-30
ISSN: 0306-4824
6 Ergebnisse
Sortierung:
In: World trade union movement: review of the World Federation of Trade Unions, Heft 12, S. 29-30
ISSN: 0306-4824
In: Acta polytechnica: journal of advanced engineering, Band 46, Heft 2
ISSN: 1805-2363
This paper presents an application of the genetic algorithm (GA) for optimizing controller gains of the Self-Excited Induction Generator (SEIG) driven by the Wind Energy Conversion Scheme (WECS). The proposed genetic algorithm is introduced to adapt the integral gains of the conventional controllers of the active and reactive control loop of the system under study, where GA calculates the optimum value for the gains of the variables based on the best dynamic performance and a domain search of the integral gains. The proposed genetic algorithm is used to regulate the terminal voltage or reactive power control, by adjusting the self excitation, and to control the mechanical input power or active power control by adapting the blade angle of WECS, in order to adjust the stator frequency. The GA is used for optimizing these gains, for an active and reactive power loop, by solving the related optimization problem. The simulation results show a better dynamic performance using the GA than using the conventional PI controller for active and reactive control.
In: Acta polytechnica: journal of advanced engineering, Band 52, Heft 2
ISSN: 1805-2363
This paper presents a powerful supervisory power system stabilizer (PSS) using an adaptive fuzzy logic controller driven by an adaptive fuzzy set (AFS). The system under study consists of two synchronous generators, each fitted with a PSS, which are connected via double transmission lines. Different types of PSS-controller techniques are considered. The proposed genetic adaptive fuzzy logic controller (GAFLC)-PSS, using 25 rules, is compared with a static fuzzy logic controller (SFLC) driven by a fixed fuzzy set (FFS) which has 49 rules. Both fuzzy logic controller (FLC) algorithms utilize the speed error and its rate of change as an input vector. The adaptive FLC algorithm uses a genetic algorithmto tune the parameters of the fuzzy set of each PSS. The FLC's are simulated and tested when the system is subjected to different disturbances under a wide range of operating points. The proposed GAFLC using AFS reduced the computational time of the FLC, where the number of rules is reduced from 49 to 25 rules. In addition, the proposed adaptive FLC driven by a genetic algorithm also reduced the complexity of the fuzzy model, while achieving a good dynamic response of the system under study.
In: Acta polytechnica: journal of advanced engineering, Band 46, Heft 2
ISSN: 1805-2363
This paper presents a novel application of a fuzzy logic controller (FLC) driven by an adaptive fuzzy set (AFS) for a power system stabilizer (PSS).The proposed FLC, driven by AFS, is compared with a classical FLC, driven by a fixed fuzzy set (FFS). Both FLC algorithms use the speed error and its rate of change as input vectors. A single generator equipped with FLC-PSS and connected to an infinite bus bar through double transmission lines is considered. Both FLCs, using AFS and FFS, are simulated and tested when the system is subjected to different step changes in the reference value. The simulation results of the proposed FLC, using the adaptive fuzzy set, give a better dynamic response of the overall system by improving the damping coefficient and decreasing the rise time and settling time compared with classical FLC using FFS. The proposed FLC using AFS also reduces the computational time of the FLC as the number of rules is reduced.
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long- term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE